Autologous blood derived cell therapy in maxillofacial bone graft surgery

Tissue regeneration is one of the ultimate goals of maxillofacial surgery and various types of tissue engineering technologies have been utilized in clin-ics. Healthy resources of host cells and growth factors are essential for the tissue engineering, therefore autologous blood-derived cell therapy was in-troduced. In this article, clinical applications of the autologous platelet concentrates and stem cell separation therapy will be summarized and evaluated for their efficacy and feasibility in the current maxillofacial clinics.

I. Introduction

II. Types of Clinically Available Autologous Blood Derived Cell Therapy

III. Controversies in Usage of Autologous Blood Derived Cell Therapy in Maxillofacial Surgery

IV. Summary and Editor’s Opinion

Author’s Contributions

Conflict of Interest

References

(0)

(0)

(0)

(0)